The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.
NCT00334425 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2006-06-13
Summary
To evaluate the effect of LH-activity supplementation during the early follicular phase in GnRHa down-regulated women undergoing IVF in terms of S-Estradiol levels on hCG day by comparing different combinations with HP-HMG and r-FSH.
Conditions
Interventions
- DRUG
-
MENOPUR; GONAL-F
Sponsors & Collaborators
-
Central Jutland Regional Hospital
lead OTHER
Principal Investigators
-
Peter Humaidan, M.D. · Fertilitetsklinikken Sygehus Viborg
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 38 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
Countries
- Denmark
Study Locations
More Related Trials
-
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
NCT07128394 ·Status: RECRUITING ·Phase: NA
-
A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism
NCT01084265 ·Status: COMPLETED ·Phase: PHASE3
-
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
NCT01798836 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
hCG Priming in Women With Diminished Ovarian Reserve
NCT07108621 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality
NCT03139474 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Gonadotropin-releasing Hormone (GnRH) Antagonist During 3 Days
NCT01093443 ·Status: COMPLETED ·Phase: PHASE4
-
GnRH for Luteal Support in IVF/ICSI/FET Cycles
NCT02357654 ·Status: RECRUITING ·Phase: PHASE4
-
GnRh Antagonist Protocol With Delayed Start Stimulation in Patients With Poor Ovarian Response
NCT03134690 ·Status: COMPLETED ·Phase: NA
-
Prolonged Protocol of Early Follicular or Mid Luteal Phase
NCT04522479 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Medication Used to Stimulate Ovulation
NCT02715336 ·Status: UNKNOWN ·Phase: PHASE4
-
GnRH Agonist for Luteal Phase Support.
NCT05484193 ·Status: UNKNOWN ·Phase: NA
-
Influence of FSH/LH Ratio in Controlled Ovarian Stimulation
NCT02994550 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety of R-hLH (Luveris ®) Priming Prior to R-HFSH Treatment in Infertile Women Undergoing IVF-ET
NCT00441324 ·Status: COMPLETED ·Phase: PHASE4
-
Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)
NCT00954811 ·Status: UNKNOWN ·Phase: PHASE4
-
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
NCT02237781 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles
NCT02908438 ·Status: UNKNOWN ·Phase: PHASE1
-
A Comparison of the Microdose Leuprolide Protocol vs. Luteal Phase Ganirelix Protocol in Women Who Are or Who Are Predicted to be Low Responders
NCT00633555 ·Status: COMPLETED
-
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
NCT01669291 ·Status: COMPLETED ·Phase: NA
-
Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)
NCT07121751 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation
NCT02449642 ·Status: COMPLETED
-
The Effects of Intrauterine Infusion of hCG at the Time of Embryo Transfer
NCT02668965 ·Status: UNKNOWN ·Phase: NA
-
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
NCT04064840 ·Status: RECRUITING ·Phase: PHASE3
-
Gonadotropin Type in Ovarian Stimulation
NCT02437032 ·Status: COMPLETED ·Phase: PHASE4
-
The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol
NCT04447872 ·Status: RECRUITING ·Phase: NA
-
Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS
NCT02827656 ·Status: UNKNOWN ·Phase: NA